1FernbergCD,PsatyBM,ManolioTA,LaupacisA,etal.Prevalenceofatrilalfibrillationinelderlysubjects (TheCardiovascularHealthStudy)[].The American Journal of Cardiology.1994 被引量：1
2SPAFⅢWritingCommitteefortheStrokePreventioninAtrialFibrillationInvestigatiors.Patientswithnonvalvularatrialfibrillationatlowriskofstrokeduringtreatmentwithaspirin:StrokePreventioninAtrialFibrllationⅢStudy[].The Journal of The American Medical Association.1998 被引量：1
6Wolf PA,Abbort RD,Kannel WB.Atrial fibriallation as an independent risk factor for stroke: the Framingham study[].Stroke.1991 被引量：1
7Moulton AW,Singer DE,Haas JS.Risk factors for stroke in patients with non- rheumatic atrial fibrillation: a case -control study[].The American Journal of Medicine.1991 被引量：1
8Cabin HS,Clubb KS,Hall C,Perlmutter RA,Feinstein AR.Risk for systemic embolization of atrial fibrillation without mitrial stenosis[].The American Journal of Cardiology.1990 被引量：1
9Stroke Prevention in Atrial Fibrillation Trial Study Group Investigation.Preliminary report of the Stroke Prevention in Atrial Fibrillation Study[].The New England Journal of Medicine.1990 被引量：1
10Petersen P.Placebo-controlled , randomised trial of warfarin and asprin for prevention of thromboembolic complications in chronic atrial fibrillation : the Copenhagen AFASAK study[].The Lancet.1989 被引量：1
